and Bcl-2 before ECT (D0) (P=0.0379, r=0.5067). In conclusion, there was no change in BAX
Introduction

55
Canine cutaneous squamous cell carcinoma (cSCC) is the most common skin cancer in 56 dogs, and the most important etiological factor is chronic sunlight exposure. On the other hand, 57 canine papillomavirus infection, chronic inflammation and immunosuppression might be 58 involved in the development of cSCC [1] [2] [3] [4] . cSCC is the second most common cutaneous tumor 59 in dogs [5] , with an incidence between 3-20% [6, 7] ; however, the incidence of cSCC depends 60 on the geographic area [5] . In humans and dogs, actinic keratosis is an SCC precursor lesion 61 with more than 80% of the SCC cases in humans being derived from previous actinic keratosis 62 [8, 9] .
63
Generally, cSCCs are locally invasive tumors with a low metastatic rate (13%) [10] [11] [12] [13] , 64 with is similar to the behavior of SCCs humans, in whom the metastatic rate is 5%; metastasis cases [1, 17] .
69
ECT is able to induce an inflammatory response, necrosis, scar tissue and apoptosis in 70 tumors [18] [19] [20] . This process is a genetically programmed process for the elimination of of mammary tumors and lymphoma [25, 26] . However, conflicting data have been observed 81 among the studies [25] [26] [27] . In feline cutaneous SCCs, neither BAX nor BCL-2 expression was 82 detected. However, in basal cell tumors, BCL-2 expression was higher (23/24) than that of 83 BAX, which was expressed only in seven out of 24 tumors. For the tumors that expressed both 84 BAX and BCL-2, the BAX:BCL-2 ratio was low [28] .
85
Another important factor to be evaluated in cSCC is cellular proliferation, which is 86 measured by the level of Ki67. It is a nuclear protein that is used to detect proliferative cells 87 because it is present in proliferating cells during the late G1, S, G2 and M phases of the cell 88 cycle, and it is correlated with poor prognosis in dogs [29] [30] [31] [32] . It is known that the high 
92
ECT has gained popularity in recent years in veterinary medicine as well as in human 93 medicine [38, 39] . ECT is a combination of chemotherapy and the localized delivery of electric 94 pulses to the tumor nodule. ECT aims to increase antineoplastic drug diffusion into the cell after 95 cell membrane electroporation, thus increasing its cytotoxicity [17] .
96
To the best of the authors' knowledge, this is the first study to evaluate the expression 97 of BAX, Bcl-2, and Ki67 in dogs with cSCC that underwent ECT. This study aimed to evaluate 
Materials and Methods
106
Ethical approval
107
This study was performed in accordance with the National and International The recommendations made by Campana et al. [40] for reporting clinical studies on ECT were 118 followed. Eighteen lesions (from 11 dogs) were selected, independent of breed, sex and age. The 126 eligibility inclusion criteria were as follows: dogs with clinically staged cSCC and complete 127 physical examinations, laboratory exams, and fine needle aspiration of regional lymph nodes.
128
Three-view thoracic radiography and abdominal ultrasonography were also performed. intravenously at a dose of 30 mg/m², followed by sequences of 8 biphasic electric pulses lasting 136 100 ms each, with a frequency of 1 Hz, 1000 V, generated by an LC BK-100 portable 137 electroporator and delivered by six needle electrodes with 0.3 mm distance between them; the 138 needle electrodes were arranged in rows (parallel array) until they achieved complete coverage 139 of the tumor. The procedure lasted until 28 minutes, according to a previous report [42, 43] .
140
All ECT procedures were administered under general anesthesia using propofol (5 141 mg/kg) IV followed by endotracheal intubation; anesthesia was maintained with isoflurane. All 
Tumor response
146
The total volume of the neoplasm was calculated by the following formula:
147
; tumor volume was measured at D0 and D21 using a digital ℎ ℎ ℎ ℎ /6 148 pachymeter [29, 30] . The same evaluator measured tumor volume to exclude measurement bias.
149
Complete remission (CR) was defined as a total reduction in measured tumor volume, while CA, USA) with a monoclonal mouse antibody used at a 1:50 dilution, applied overnight. After 
Immunohistochemical evaluation
193
The immunohistochemical slides were examined with a light microscope using an 
Results
234
Clinical data 235 Mixed breed dogs (n=5) were the dogs most commonly affected by cSCC, followed
236
by American Pit Bulls (n=3), Boxers (n=2) and English Pointers (n=1). All subjects had sparse 237 fur and lightly pigmented skin. The mean age of the animals was 7.5 (± 2.29) years, with 238 females being the more common sex (n=10). Five animals had more than one lesion. Thus, we 239 investigated 18 lesions in 11 subjects.
240
The most commonly affected sites observed were the abdominal region (n=10),
241
followed by the thoracic region (n=5), axillar region (n=1), preputial region (n=1) and tibial 242 region (n=1). Among the 11 subjects, only three had regional lymph node involvement at the 243 time of diagnosis. There was no difference in survival time between subjects with and without 244 lymph node involvement (S Fig 1A) (P> 0.05). Among the 18 lesions, the volume before the treatment ranged from 0.14 to 112.9 cm³
251
(median of 4.64), and the volume decreased significantly after treatment (p=0.04), ranging from 252 0.11 to 118.2 cm³ (median of 1.49) ( Table 1 ) (Fig 1A) . impact on survival time (Fig 1B) and had no prognostic value (P>0.05). and larger than 5 cm 3 . The volume at D0 had no impact on survival time and had no prognostic 278 value (P>0.05), and the response to ECT was not significant (p=0.332).
280
In addition, the association between the clinical stage before treatment (D0) and the 281 response to ECT was not significant (p=0.332) (Fig 1B) . The median survival time of the 11 282 dogs was 180 days (32 to 570 days) (Fig 2A) . The additional clinical results are shown in Table 1 . The number of sessions that each 288 subject underwent ranged from one to three. Five subjects underwent a surgical procedure after 289 D21 (four due to PD and one due to the owner request).
291
Histopathological features
292
Regarding the histopathological grade, 16 lesions (83.3%) were classified as well-293 differentiated SCC ( Suppl Fig 2A) , and three (16.6%) were classified as poorly differentiated 294 SCC (Suppl Fig 2B) . Interestingly, only well-differentiated tumors progressed, and all (3/18) 295 poorly differentiated cSCC experienced PR.
296
The median mitotic index in the tumor group at D0 was 4.94 (0 to 34). We found a 297 relationship between the mitotic index and overall survival. Subjects with mitosis numbers 298 lower than 4.9 at D0 experienced a longer survival time (P=0.009) (Fig 2B) . (Fig 1C) . We also assessed intratumoral necrosis in the 311 tumor samples at D0 and D21. It is not surprising that we found more necrosis in tumors at D21 15 312 than at D0 (P=0.041) (Fig 1D) . We evaluated necrosis at D0 and the survival time, and we did 313 not find significant differences (P>0.05). expression between D0 and D21 (Fig 3 A and B) . Thus, tumor samples after ECT (D21) had a 326 lower proliferative index than those before ECT (p=0.031) ( Figure 1E ). Using the proliferative 327 index at D0, we evaluated the survival time between subjects with Ki67 values lower and higher 328 than the median Ki67 value, and we did not find a significant difference (P>0.05). For BAX and Bcl-2, cytoplasmic expression was identified (Fig 4A) . We found 340 median BAX expression levels of 21.02% (ranging from 8.34 to 70.56) at D0 and 24.53%
341
(ranging from 10 to 74.47) at D21. There was no significant difference in BAX expression 342 between D0 and D21 (P>0.05) (Fig 4B) . There was no significant difference in overall survival 343 between subjects with low and high BAX expression levels (P>0.05) (Suppl Fig 1C) . survival between subjects with high and low levels of BAX (P>0.05).
354
Regarding Bcl-2 expression (Fig 4C) , we found medians of 20.62% (ranging from 355 2.76% to 48.37) at D0 and 26.42% at D21 (ranging from 0.65 to 77.23). There was no 356 statistically significant difference in Bcl-2 expression between D0 and D21 (P>0.05) (Fig 4D) .
357
When we evaluated the survival time between samples with low Bcl-2 expression versus those
358
with high expression, we did not find a significant difference (P>0.05) (Suppl Fig 1D) .
359
Furthermore, a positive correlation was observed between BAX/Bcl-2 expression levels 360 before ECT (D0) (p=0.0379, r=0.5067) (Fig 4E) . However, after treatment (D21), we did not 
Western blot analysis
372
We found a 26-kDa band for Bcl-2 and a 21-kDa band size for BAX. Both antibodies
373
showed only one band each in the western blot analysis (Fig 5) . a local approach is required to achieve long-term disease-free interval and overall survival.
380
Surgery is the primary treatment for cSCC. However, many patients have multiple tumors at 381 the time of diagnosis, making surgical approaches difficult. Therefore, new techniques are 382 required to improve the outcomes of canine patients with cSCC.
383
In this study, we evaluated ECT as a primary therapy for cSCC. We determined the 
399
Among the limiting factors of our study, there was an absence of a cutoff point for tumor 400 size in cutaneous neoplasms in dogs, unlike in human medicine. In addition, the staging adopted 401 in veterinary medicine does not take into account the size of the subject, which may influence 402 the behavior of a tumor of the same size in dogs of different sizes. The small sample size is also 403 a limitation of our study. However, we performed a G power analysis to guarantee that our 404 tumor group had a sufficient number of samples.
405
Interestingly, lymph node involvement was not a prognostic factor in dogs with cSCC.
406
The number and size of the lesions seems to be more important than the involvement of local Medicine, a limited number of studies have demonstrated the ECT antitumoral effect in cSCC.
420
In general, the high expression level of Ki67 observed in SCC, especially in poorly 421 differentiated SCC, is related to an aggressive potential [9, 34, 37, 49] . However, in the lesions 422 studied, the proliferation index could also be considered high despite the predominance of well- 
